SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-040053
Filing Date
2014-05-19
Accepted
2014-05-19 16:01:10
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-11928_110q.htm 10-Q 729828
2 EX-31.1 a14-11928_1ex31d1.htm EX-31.1 9687
3 EX-31.2 a14-11928_1ex31d2.htm EX-31.2 9724
4 EX-32.1 a14-11928_1ex32d1.htm EX-32.1 6304
5 EX-32.2 a14-11928_1ex32d2.htm EX-32.2 6315
  Complete submission text file 0001104659-14-040053.txt   6456095

Data Files

Seq Description Document Type Size
6 EX-101.INS fcsc-20140331.xml EX-101.INS 822491
7 EX-101.SCH fcsc-20140331.xsd EX-101.SCH 66717
8 EX-101.CAL fcsc-20140331_cal.xml EX-101.CAL 40319
9 EX-101.DEF fcsc-20140331_def.xml EX-101.DEF 353980
10 EX-101.LAB fcsc-20140331_lab.xml EX-101.LAB 965761
11 EX-101.PRE fcsc-20140331_pre.xml EX-101.PRE 519113
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 14854626
SIC: 2834 Pharmaceutical Preparations